Lingzhi Red Reishi (Ganoderma lucidum)
Lingzhi Red Reishi (Ganoderma lucidum) is a medicinal fungus whose primary bioactive compounds — β-glucans and triterpenes such as ganoderic acids — drive its immunomodulatory and adaptogenic effects. These compounds activate peripheral immune cells via Toll-like receptor 2 and Dectin-1 signaling, upregulating cytokine production and natural killer cell activity.

Origin & History
Lingzhi Red Reishi (Ganoderma lucidum) is a medicinal mushroom native to East Asia, particularly China, Japan, and Korea, growing on hardwood trees like oak and maple. It is a basidiomycete fungus with extracts typically obtained via hot water, ethanol, or dual extraction methods to isolate polysaccharides and triterpenes.
Historical & Cultural Context
Used for over 2,000 years in Traditional Chinese Medicine (TCM) as 'Lingzhi' for longevity, immunity, vitality, and chronic conditions like fatigue and inflammation. Known as Reishi in Japan, it has been integral to TCM formulations for immune support and anti-aging.
Health Benefits
• Immune system modulation through β-glucan activation of peripheral immune cells (Strong evidence from RCT in children, PMID: 30317947) • Modest reduction in BMI based on recent meta-analysis of RCTs using 200-11,200 mg/day (Moderate evidence, PMC12160064) • Potential analgesic effects for rheumatoid arthritis when combined with San Miao San (Preliminary evidence from pilot RCT, PMID: 17907228) • Improved prostate symptoms with ethanol extract showing 2.1 point IPSS improvement (Moderate evidence from RCT, PMID: 18097505) • No significant effects on blood glucose, HbA1c, or lipids in type 2 diabetes (Strong evidence from meta-analysis of 5 RCTs, PMID: 25686270)
How It Works
Reishi's β-glucans bind to Dectin-1 and TLR-2 receptors on macrophages, dendritic cells, and NK cells, triggering NF-κB and MAPK signaling cascades that upregulate pro-inflammatory and regulatory cytokines including TNF-α, IL-6, and IL-10. Triterpenes, specifically ganoderic acids A, B, and C, inhibit HMG-CoA reductase and 5α-reductase, contributing to lipid modulation and anti-androgenic activity. Additionally, polysaccharide fractions suppress COX-2 expression and prostaglandin E2 synthesis, providing a biochemical basis for observed analgesic and anti-inflammatory effects.
Scientific Research
A meta-analysis of 5 RCTs (n=398) using 1.4-3 g/day for 12-16 weeks found no significant effects on blood glucose, pressure, or lipids in type 2 diabetes patients (PMID: 25686270). A double-blind RCT (n=84) in type 2 diabetes with metabolic syndrome showed no reduction in HbA1c after 16 weeks (PMC4980683). However, recent meta-analysis (PMC12160064) of RCTs using 200-11,200 mg/day for 1-24 weeks showed modest reductions in BMI, creatinine, and heart rate.
Clinical Summary
A randomized controlled trial (PMID: 30317947) demonstrated statistically significant immune activation in children receiving Ganoderma lucidum extract, evidenced by increased NK cell counts and immunoglobulin levels. A 2025 meta-analysis (PMC12160064) pooling multiple RCTs using doses of 200–11,200 mg/day found a modest but significant reduction in BMI, though effect sizes were small and heterogeneity was notable. Evidence for analgesic effects in rheumatological conditions is preliminary, with most data derived from small pilot trials and animal models rather than large-scale RCTs. Overall, immune modulation carries the strongest clinical evidence grade, while metabolic and pain-related benefits require larger confirmatory trials.
Nutritional Profile
{"macronutrients": {"protein": "2.5-3.5 g per 100 g", "fiber": "6-8 g per 100 g"}, "micronutrients": {"vitamins": {"Vitamin B2 (Riboflavin)": "0.2-0.3 mg per 100 g", "Vitamin B3 (Niacin)": "2.0-2.5 mg per 100 g"}, "minerals": {"Potassium": "1500-2000 mg per 100 g", "Phosphorus": "200-250 mg per 100 g", "Calcium": "20-30 mg per 100 g", "Magnesium": "80-100 mg per 100 g"}}, "bioactive_compounds": {"Polysaccharides": "30-40% of dry weight", "Triterpenoids": "1-2% of dry weight", "\u03b2-glucans": "5-10% of dry weight"}, "bioavailability_notes": "The bioavailability of polysaccharides and triterpenoids can be enhanced through hot water extraction. \u03b2-glucans are more bioavailable when consumed in powdered or extract form."}
Preparation & Dosage
Clinically studied doses range from 1.4-3 g/day of raw/powder equivalent for 12-16 weeks in cardiovascular and diabetes trials. Broader studies have used 200-11,200 mg/day of various extract forms for 1-24 weeks. Polysaccharide and ethanol extracts are commonly standardized to β-glucan content. Consult a healthcare provider before starting any new supplement.
Synergy & Pairings
Vitamin D3, Zinc, Astragalus, Turkey Tail mushroom, Vitamin C
Safety & Interactions
Reishi is generally well tolerated at doses up to 5.4 g/day of whole mushroom extract for periods up to 16 weeks, with the most commonly reported side effects being mild gastrointestinal upset, dry mouth, and dizziness. It carries a clinically significant interaction risk with anticoagulant and antiplatelet drugs (e.g., warfarin, aspirin) due to its inhibition of platelet aggregation mediated by adenosine and ganoderic acid derivatives, potentially increasing bleeding risk. Reishi may also have additive hypoglycemic effects when combined with insulin or oral antidiabetic agents, necessitating blood glucose monitoring. Safety data in pregnancy and lactation are insufficient, so use is not recommended in these populations; individuals with autoimmune conditions should consult a physician before use given its immune-stimulating properties.